Shares Magazine
283.60p+2.60 (+0.93%)18 Apr 2024, 18:14
Jump to:
Convatec Group PLC Fundamentals
| Company Name | Convatec Group PLC | Last Updated | 2024-04-18 |
|---|---|---|---|
| Industry | Medical Instruments & Supplies | Sector | Healthcare |
| Shares in Issue | 2.050 bn | Market Cap | £5.81 bn |
| PE Ratio | 55.44 | Dividend per Share | $0.06 |
| Dividend Yield | 1.79 | Dividend Cover | 1.00 |
| EPS | $0.06 | EPS Growth (%) | 0.36 |
| PEG | 2.35 | DPS Growth (%) | 0.0842 |
| Debt Ratio | 0.3534 | Debt Equity Ratio | 0.7631 |
| Asset Equity Ratio | 2.1940 | Cash Equity Ratio | 0.0577 |
| Quick Ratio | 0.7576 | Current Ratio | 1.62 |
| Price To Book Value | 4.2772 | ROCE | 0 |
Convatec Group PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Prelim | 2024-04-25 | 2024-05-23 | GBP | 0.0352 | |
| Interim | 2023-08-17 | 2023-09-28 | GBP | 0.0138 | |
| Prelim | 2023-04-06 | 2023-05-25 | GBP | 0.0366 | |
| Interim | 2022-08-25 | 2022-10-06 | GBP | 0.0141 | |
| Prelim | 2022-03-31 | 2022-05-19 | GBP | 0.0316 | |
| Interim | 2021-09-02 | 2021-10-14 | GBP | 0.0123 | |
| Prelim | 2021-04-01 | 2021-05-13 | GBP | 0.0284 |
Convatec Group PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | $548.50 m | $479.80 m | $450.30 m |
| Intangible Assets | $2.23 bn | $2.15 bn | $2.06 bn |
| Investments | $22.90 m | $30.70 m | 0 |
| Total Fixed Assets | $2.84 bn | $2.70 bn | $2.56 bn |
| Stocks | $396.10 m | $336.90 m | $308.80 m |
| Debtors | $308.80 m | $314.60 m | $301.50 m |
| Cash & Equivalents | $97.60 m | $143.80 m | $463.40 m |
| Other Assets | $38.20 m | $42.70 m | $54.40 m |
| Total Assets | $3.71 bn | $3.59 bn | $3.67 bn |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | $536.40 m | $533.10 m | $569.20 m |
| Creditors after 1 year | $1.48 bn | $1.45 bn | $1.41 bn |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $2.02 bn | $1.98 bn | $1.98 bn |
| Net assets | $1.69 bn | $1.61 bn | $1.69 bn |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | $251.50 m | $250.70 m | $247.00 m |
| Share Premium | $181.00 m | $165.70 m | $142.30 m |
| Profit / Loss | $167.40 m | $81.90 m | $151.30 m |
| Other Equity | $1.69 bn | $1.61 bn | $1.69 bn |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $1.69 bn | $1.61 bn | $1.69 bn |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | $0.43 | $0.44 | $0.43 |
| Debt-to-Equity | $0.76 | $0.80 | $0.75 |
| Assets / Equity | 2.1940 | 2.1940 | 2.1940 |
| Cash / Equity | 0.0577 | 0.0577 | 0.0577 |
| EPS | $0.07 | $0.05 | $0.06 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | $367.40 m | $281.70 m | $305.90 m |
| Cashflow before financing | $243.40 m | $44.60 m | $106.00 m |
| Increase in Cash | -$42.30 m | -$303.70 m | -$100.50 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | $2.14 bn | $2.07 bn | $2.04 bn |
| Cost of sales | $941.80 m | $968.60 m | $915.20 m |
| Gross Profit | $1.20 bn | $1.10 bn | $1.12 bn |
| Operating Profit | $262.70 m | $207.30 m | $203.60 m |
| Pre-Tax profit | $167.40 m | $81.90 m | $151.30 m |
Convatec Group PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue. |
| Latest Interim Date | 2 Aug 2023 |
| Latest Fiscal Year End Date | 6 Mar 2024 |
Convatec Group PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-03-22 | Ms. Heather L. Mason | Non-Executive Director |
| 2019-06-28 | Mr. Jesper Ovesen | Non-Executive Director |
| 2019-05-09 | Sir Christopher Charles Gent | Non-Executive Director,Chairman |
| 2022-02-28 | Mr. Rick D. Anderson | Non-Executive Director |
| 2018-02-27 | Mr. Nigel Clerkin | Executive Director,Chief Financial Officer |
| 2023-09-08 | Professor Sten Scheibye | Non-Executive Director |
| 2019-03-31 | Mr. Steven John Holliday | Non-Executive Director,Deputy Chairman |
| 2024-03-22 | Dr. John David Gibson McAdam CBE | Non-Executive Director,Chairman |
| 2024-03-22 | Mr. Brian Michael May | Non-Executive Director |
| 2024-03-22 | Ms. Margaret Ewing | Non-Executive Director,Senior Independent Director |
| 2024-03-12 | Mr. Karim Bitar | Executive Director,Chief Executive Officer |
| 2024-03-22 | Ms. Kimberly S. Lody | Non-Executive Director |
| 2020-08-31 | Dr. Rosalind Catherine Rivaz | Non-Executive Director |
| 2024-03-22 | Ms. Sharon L. O’Keefe | Non-Executive Director |
| 2023-03-22 | Dr. Regina M. Benjamin, M.D. | Non-Executive Director |
| 2019-02-27 | Mr. Paul Moraviec | Executive Director,Chief Executive Officer |
| 2018-07-03 | Mr. Kasim Kutay | Non-Executive Director |
| 2021-12-16 | Mr. Frank Maria Schulkes | Executive Director,Chief Financial Officer |
| 2024-03-22 | Professor Constantin Coussios OBE | Non-Executive Director |
| 2024-03-22 | Mr. Jonny Mason | Executive Director,Chief Financial Officer |
Convatec Group PLC Contact Details
| Company Name | ConvaTec Group PLC |
|---|---|
| Address | 23 Forbury Road, 3 Forbury Place, Reading, RG1 3JH |
| Telephone | +44 1189528100 |
| Website | https://www.convatecgroup.com |
Convatec Group PLC Advisors
| Remuneration Consultant | Kepler Associates |
|---|---|
| Phone | +44 2079307730 |
| Fax | +44 2079307733 |
| Stockbroker | UBS Limited |
|---|---|
| Phone | +44 2075678000 |
| Stockbroker | Goldman Sachs International |
|---|---|
| Phone | +44 2077741000 |
| Financial Adviser | Evercore Partners |
|---|---|
| Phone | +44 2076536000 |
| Fax | +44 2076536001 |
| Financial PR Adviser | Finsbury |
|---|---|
| Phone | +44 2072513801 |
| Fax | +44 2073744133 |
| Auditor | Deloitte LLP |
|---|---|
| Phone | +44 2079363000 |
| Fax | +44 2075831198 |
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
| Solicitor | Freshfields Bruckhaus Deringer |
|---|---|
| Phone | +44 2079364000 |
| Fax | +44 2078327001 |
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Hipgnosis Songs Fund Limited | 92.00 | 30.50 |
| Wizz Air Holdings PLC | 2,118.00 | 6.59 |
| International Consolidated Airlines Group S.A. | 169.80 | 5.66 |
| Wood Group (John) PLC | 151.00 | 5.45 |
| Prudential PLC | 722.80 | 4.42 |
| Dr. Martens PLC | 69.85 | 4.25 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Rentokil Initial PLC | 412.90 | -7.61 |
| Dunelm Group PLC | 995.50 | -7.31 |
| Future PLC | 631.50 | -4.39 |
| Watches Of Switzerland Group PLC | 336.00 | -3.89 |
| Vesuvius PLC | 457.50 | -3.68 |
| Quilter PLC | 99.00 | -3.41 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.